Methicillin-Resistant Staphylococcus Aureus (MRSA) Bloodstream Infections In Long-Term Acute Care, 2013
Published By U.S. Department of Health & Human Services
Issued about 9 years ago
Summary
Description
Long-term acute care hospitals (LTACs) are defined by the Centers for Medicare and Medicaid Services as providing care to patients with medically complex conditions requiring an average length of stay greater than 25 days. This table shows the incidence rates of hospital onset (HO) methicillin-resistant Staphylococcus aureus bloodstream infections (MRSA BSI) reported by California LTACs to the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN), during the time period January through December 2013. MRSA BSI cases are classified as HO when a positive blood sample is obtained on day four or later during a hospital stay, from a patient with no prior positive blood culture within the preceding two weeks. The HO MRSA BSI rate is calculated by dividing the number of cases by the total number of patient days; the rate is then reported per 10,000 patient days. The MRSA BSI rates in this data release are not risk adjusted because there are no such methods available at this time for LTACs. In addition to patient-based risk factors, the unadjusted LTAC MRSA BSI rates herein are also affected by facility bed size, community prevalence rate, clinical and infection control practices, and/or surveillance methods. While stratifying MRSA BSI rates by LTAC hospital type may make rates more comparable, it cannot control for all factors that can affect MRSA BSI rates. Therefore, comparisons between hospitals within this group should still be made with caution. To link the CDPH facility IDs with those from other Departments, like OSHPD, please reference the "Licensed Facility Cross-Walk" Open Data table at https://chhs.data.ca.gov/Facilities-and-Services/Licensed-Facility-Cross...